<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">problendo</journal-id><journal-title-group><journal-title xml:lang="ru">Проблемы Эндокринологии</journal-title><trans-title-group xml:lang="en"><trans-title>Problems of Endocrinology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0375-9660</issn><issn pub-type="epub">2308-1430</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/probl201662566-67</article-id><article-id custom-type="elpub" pub-id-type="custom">problendo-8107</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Краткое сообщение</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Short Messages</subject></subj-group></article-categories><title-group><article-title>Уровень кортизола в сыворотке как предиктор развития надпочечниковой недостаточности у пациентов в раннем послеоперационном периоде после проведения нейрохирургического вмешательства транссфеноидальным доступом</article-title><trans-title-group xml:lang="en"><trans-title>Serum cortisol in the early post operative period after transphenoidal surgery to predict adrenal insufficiency</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>González Molero</surname><given-names>Inmaculada</given-names></name><name name-style="western" xml:lang="en"><surname>González Molero</surname><given-names>Inmaculada</given-names></name></name-alternatives><bio xml:lang="ru"><p>Malaga Regional Hospital</p></bio><bio xml:lang="en"><p>Endocrinolgy Department</p></bio><email xlink:type="simple">inmagonzalezmolero@hotmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Gonzalez</surname><given-names>Laura</given-names></name><name name-style="western" xml:lang="en"><surname>Gonzalez</surname><given-names>Laura</given-names></name></name-alternatives><bio xml:lang="ru"><p>Neurosyrgery Department</p></bio><bio xml:lang="en"><p>Neurosyrgery Department</p></bio><email xlink:type="simple">inmagonzalezmolero@hotmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Garcia Arnes</surname><given-names>Juan</given-names></name><name name-style="western" xml:lang="en"><surname>Garcia Arnes</surname><given-names>Juan</given-names></name></name-alternatives><bio xml:lang="ru"><p>Malaga Regional Hospital</p></bio><bio xml:lang="en"><p>Malaga Regional Hospital</p></bio><email xlink:type="simple">inmagonzalezmolero@hotmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Maraver</surname><given-names>Silvia</given-names></name><name name-style="western" xml:lang="en"><surname>Maraver</surname><given-names>Silvia</given-names></name></name-alternatives><bio xml:lang="ru"><p>Virgen de la Victoria Hospital</p></bio><bio xml:lang="en"><p>Virgen de la Victoria Hospital</p></bio><email xlink:type="simple">inmagonzalezmolero@hotmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Olveira</surname><given-names>Gabriel</given-names></name><name name-style="western" xml:lang="en"><surname>Olveira</surname><given-names>Gabriel</given-names></name></name-alternatives><bio xml:lang="ru"><p>Endocrinolgy Department</p></bio><bio xml:lang="en"><p>Endocrinolgy Department</p></bio><email xlink:type="simple">inmagonzalezmolero@hotmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Arraez</surname><given-names>Miguel Angel</given-names></name><name name-style="western" xml:lang="en"><surname>Arraez</surname><given-names>Miguel Angel</given-names></name></name-alternatives><bio xml:lang="ru"><p>Endocrinolgy Department</p></bio><bio xml:lang="en"><p>Neurosyrgery Department</p></bio><email xlink:type="simple">inmagonzalezmolero@hotmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Tinahones</surname><given-names>Francisco</given-names></name><name name-style="western" xml:lang="en"><surname>Tinahones</surname><given-names>Francisco</given-names></name></name-alternatives><bio xml:lang="ru"><p>Endocrinolgy Department</p></bio><bio xml:lang="en"><p>Endocrinolgy Department</p></bio><email xlink:type="simple">inmagonzalezmolero@hotmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Malaga Regional Hospital</institution><country>Испания</country></aff><aff xml:lang="en"><institution>Malaga Regional Hospital</institution><country>Spain</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Malaga University</institution><country>Испания</country></aff><aff xml:lang="en"><institution>Malaga University</institution><country>Spain</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Endocrinolgy Department. Virgen de la Victoria Hospital</institution><country>Испания</country></aff><aff xml:lang="en"><institution>Endocrinolgy Department. Virgen de la Victoria Hospital</institution><country>Spain</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>22</day><month>09</month><year>2016</year></pub-date><volume>62</volume><issue>5</issue><issue-title>ТЕЗИСЫ ДОКЛАДОВ 4-й конференции Европейской ассоциации молодых эндокринологов</issue-title><fpage>66</fpage><lpage>67</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; González Molero I., Gonzalez L., Garcia Arnes J., Maraver S., Olveira G., Arraez M., Tinahones F., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">González Molero I., Gonzalez L., Garcia Arnes J., Maraver S., Olveira G., Arraez M., Tinahones F.</copyright-holder><copyright-holder xml:lang="en">González Molero I., Gonzalez L., Garcia Arnes J., Maraver S., Olveira G., Arraez M., Tinahones F.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.probl-endojournals.ru/jour/article/view/8107">https://www.probl-endojournals.ru/jour/article/view/8107</self-uri><abstract><p>Надпочечниковая недостаточность является частым осложнением после транссфеноидального хирургического вмешательства по поводу аденомы гипофиза. Необходимо идентифицировать пациентов, нуждающихся в заместительной терапии глюкокортикидами для предупреждения развития у них надпочечниковой недостаточности.</p><sec><title>Цель исследования</title><p>Цель исследования: для установления вторичной надпочечниковой недостаточности в раннем послеоперационном периоде (3 сутки) было проведено определение утреннего кортизола (8.00 утра)</p></sec><sec><title>Результаты</title><p>Результаты: данные были получены от 20 пациентов (9 мужчин, средний возраст 52.8 лет), 18 с макроаденомами, 8 пациентов с болезнью Кушинга. Пациенты с аденомами и без болезни Кушинга: у всех пациентов с уровнем кортизола на 3и сутки послеоперационного периода больше 15 мкг/дл отмечался нормальный уровень кортизола во время пробы с синактеном спустя 6 месяцев. У 2 пациентов с уровнем кортизола на 3и сутки послеоперационного периода от 10 до 15 мкг/дл отмечалось наличие надпочечниковой недостаточности спустя 6 месяцев после операции. У всех пациентов с болезнью Кушинга с уровнем кортизола на 3и сутки послеоперационного периода более 10 мкг/дл не отмечалось надпочечниковой недостаточности спустя 6 месяцев после операции. У всех пациентов с уровнем кортизола на 3и сутки послеоперационного периода менее 10 мкг/дл не отмечалось рецидивов, за исключением одного с развившейся надпочечниковой недостаточностью</p></sec><sec><title>Заключение</title><p>Заключение: уровень кортизола более 15 мкг/дл на 3и сутки послеоперационного периода является безопасной отрезной точкой для исключения надпочечниковой недостаточности. У пациентов с болезнью Кушинга уровень кортизола менее 10 мкг/дл является показателем низкой вероятности рецидива.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. Adrenal insufficiency is a common complication of transsphenoidal surgery (TSS) for pituitary adenoma. It is very important to identify patients requiring glucocorticoid replacement, minimising risks of adrenal insufficiency.</p></sec><sec><title>Aim</title><p>Aim: to assess the performance of early ( 3ºday) post-TSS 08:00 a.m. cortisol measurement to detect and exclude secondary adrenal insufficiency.</p></sec><sec><title>Methods</title><p>Methods. We selected patients undergoing TSS in our hospital during 12 months and performed a 3º day postoperative 08:00 a.m. cortisol measurement and cortisol+/-Synachten 6 months post-surgery. All patients received perioperative glucocorticoid replacement (First and second days postsurgery) unless basal cortisol was &gt; 10 microg/dl and cortisol after Synachten &gt; 23 microg/dl previous to surgery. We excluded patients with previous diagnosed and treated adrenal insuficiency. In patients with 3º day cortisol lower than 10 microg/dl we maintained glucocorticoid treatment until reevaluation with cortisol/Synachten 6 months post-surgery.In patients with 3º day cortisol higher than 10 microg/dl glucocorticoids were discontinued.</p></sec><sec><title>Results</title><p>Results. Data were reviewed from 20 patients (9 males, mean age 52,8 years), 18 with macroadenomas, 8 patients with cushing disease. Patients with adenomas no cushing: all patients with 3º day cortisol &gt; 15 microg/dl had normal cortisol/Synachten 6 months post-surgery. 2 patients with 3º day cortisol between 10 and 15 microg/dl had adrenal insufficiency 6 months postsurgery.1 patient with 3º day cortisol&lt; 10 microg/dl mantained adrenal insuficiency 6 months postsurgery. Cushing disease: all patients with 3º day cortisol &gt; 10 microg/dl had not adrenal insuficiency 6 months postsurgery, all except one with recurrence. All patients with 3º day cortisol &lt;10 microg/dl had not recurrences, all except one with adrenal insufficiency.</p></sec><sec><title>Conclusion</title><p>Conclusion. A 3º day post-TSS cortisol &gt; 15 microg/dl is a safe cutt off to discarge adrenal insufficiency. In cushing disease, a level &lt; 10 microg/dl predict a low likelihood of recurrences.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>гипофиз</kwd><kwd>кортизол</kwd><kwd>хирургия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>pituitary</kwd><kwd>cortisol</kwd><kwd>surgery</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
